Impact of carcinoma in situ on survival of patients treated by adjuvant chemotherapy after cystectomy

This publication has 20 references indexed in Scilit:

• Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder Cancer
  Journal of Clinical Oncology, 2016
• Diagnosis and Management of Urothelial Carcinoma In Situ of the Lower Urinary Tract: A Systematic Review
  European Urology, 2015
• Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial
  The Lancet Oncology, 2015
• The Effect of Concomitant Carcinoma In Situ on Neoadjuvant Chemotherapy for Urothelial Cell Carcinoma of the Bladder: Inferior Pathological Outcomes but No Effect on Survival
  Journal of Urology, 2014
• Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized Trials
  European Urology, 2014
• Natural history of pT3-4 or node positive bladder cancer treated with radical cystectomy and no neoadjuvant chemotherapy in a contemporary North-American multi-institutional cohort
  Canadian Urological Association Journal, 2012
• Upper Urinary Tract Recurrence Following Radical Cystectomy for Bladder Cancer: A Meta-Analysis on 13,185 Patients
  Journal of Urology, 2012
• Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer Is Low Among Major European Centres: Results of a Feasibility Questionnaire
  European Urology, 2012
• Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer
  International Journal of Urology, 2008
• MULTIVARIATE ANALYSIS OF THE PROGNOSTIC FACTORS OF PRIMARY SUPERFICIAL BLADDER CANCER
  Journal of Urology, 2000